Lebanon, NH—Dartmouth researchers developed a new biological pathway-based computational model, called the Pathway-based Human Phenotype Network (PHPN), to identify underlying genetic connections between different diseases as reported in BioDataMining; this week. The PHPN mines the data present in large publicly available disease datasets to find shared SNPs, genes, or pathways and […]
Catherine Pipas, MD, director of the leadership component of the new curriculum at Geisel and a professor of community and family medicine, has been appointed a Faculty Member of the Association of American Medical Colleges’ Leadership Education and Development Program.
Dr. Holly Atkinson’s experiences in human rights work over the past 25 years have given her reason to be both deeply troubled and incredibly hopeful. Last week, at a symposium organized by the Geisel chapter of Physicians for Human Rights, she discussed both ends of the spectrum, from the worries that keep her up at night to the people who have inspired her.
The Choosing Wisely campaign, lists of services developed by physicians’ specialty societies, is a good start to spark discussion between physicians their patients about treatments and tests that may not be warranted.
Dartmouth engineers and radiologists are developing new approaches for an emerging technique in diagnostic imaging for breast cancer—MRI with near-infrared spectroscopy (NIRS).
Dartmouth Medicine asked geneticist Jason Moore about his thoughts on the FDA’s decision to order 23andMe, a company that provides personal genetic testing, to stop selling its genetic test for health-related purposes.
From a patient’s bedside in Mexico, Rosa Hernandez saw her future as a healer. Discover more about this first-year medical student’s journey from Los Angeles to MIT to Clínica Guadalupana in Mexico to Geisel and Dartmouth.
A scientific breakthrough may give the field of radiation oncology new tools to increase the precision and safety of radiation treatment in cancer patients by helping doctors “see” the powerful beams of a linear accelerator as they enter or exit the body.
A new statistical approach to measuring the cancer burden in the United States reveals decades of progress in fighting cancer, progress previously masked by the falling death rates of other diseases.
Research carried out in two distinct communities in Colombia illustrates how coevolution between humans and bacteria can affect a person’s risk of disease.